Glucagon-like peptide-1 (GLP-1)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Glucagon-like peptide-1 (GLP-1), covering 2014-06-25 to 2014-06-25. Get the full timeline:
Most recent: Clinical Trial Update: Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes. [Phase 4]